A ₹10,000 crore medical hub is coming to Navi Mumbai

Cleveland Clinic leads a 250-acre health project creating 10,000 jobs near the upcoming international airport.

Navi Mumbai | editorial@unboxdailyhq.com
At Unbox Daily HQ, discovery matters more than speed. If it's here, we believe it's worth your time.

The Essentials

  • Cleveland Clinic and Brookfield have partnered with the Maharashtra government to build an integrated health campus.
  • The 250-acre facility will attract approximately ₹10,000 crore in investment and create over 10,000 direct jobs.
  • Patients will gain access to AI-driven genomics research and clinical care directly adjacent to the new airport.

The Pulse

The Maharashtra government just signed off on a massive medical infrastructure deal that puts Navi Mumbai squarely on the global healthcare map. Cleveland Clinic, Brookfield Asset Management, and Arodhan Health City are building an integrated clinical and research campus right next to the upcoming Navi Mumbai International Airport.

If you are wondering when and where this is happening, the Navi Mumbai International MediCity is a 250-acre project officially confirmed on June 10, 2026, aimed at combining patient care, nursing education, and biotechnology under one roof.

Rather than just building another large hospital, the consortium is creating an entire hub for advanced medical delivery. Cleveland Clinic acts as the anchor institution, bringing its specific expertise in cardiovascular medicine and patient-centric care to the country. With direct support from the state government to clear approvals, this development marks a clear shift towards large-scale, specialised healthcare infrastructure.

The Snapshot

SpecificationDetails
Project NameNavi Mumbai International MediCity (NMIMC)
Location250 acres adjacent to Navi Mumbai International Airport
Investment$1.2 billion (approximately ₹10,000 crore)
Anchor InstitutionCleveland Clinic (Ohio, USA)
Real Estate PartnerBrookfield Asset Management
Key Focus AreasSuper-specialty hospitals, clinical research, AI genomics, biotech
Job CreationOver 10,000 direct roles
StatusMoU signed last week

The Big Picture

Corporate healthcare in India has traditionally been dominated by domestic giants like Apollo Hospitals and Manipal. Bringing an American heavyweight like Cleveland Clinic into a physical space within Maharashtra shifts that dynamic entirely. The project aligns directly with the central government’s “Heal in India” initiative, aiming to capture a larger slice of the global medical tourism market. By combining biotechnology, AI-driven health systems, and clinical care in a single campus, this development pressures existing hospital networks to invest more heavily in integrated clinical research rather than just standard patient beds.

The India Prospective

Location is the deciding factor here. Siting this campus directly adjacent to the new Navi Mumbai International Airport in what is being developed as “Third Mumbai” guarantees immediate accessibility. For Indian patients seeking complex treatments or clinical trials, this eliminates the need to travel abroad. It also positions the region to draw in international medical tourists the moment they step off their flights.

The Inside Intel

The boardroom weight behind this project is highly unusual for a standard hospital development. The MoU signing brought together top executives from Cleveland Clinic, including their CEO and the Chairman of Cardiovascular Medicine, alongside Lakshmi Mittal. Mittal’s presence as both the Executive Chairman of ArcelorMittal and a board member of the clinic highlights the sheer scale of cross-industry corporate backing this medical campus commands.

The Unboxed Truth

Unbox Daily HQ views this as a definitive upgrade for Indian medical infrastructure. If you are tracking healthcare investments or anticipating complex care needs over the next decade, this is the project to watch. The sheer volume of capital and the involvement of a global hospital brand mean expectations for clinical outcomes will be exceptionally high. The real value lies in the integration of active research with daily patient care, bringing advanced treatments to India much faster.

Best for: medical professionals and clinical researchers who want to work alongside an international anchor institution

Who Is This For: Perfect for 28 to 55 year old healthcare investors, medical students, and future patients in Maharashtra who prioritise integrated, research-backed medical facilities

The Checkout

Cleveland Clinic – Global Page

The Source

Government of Maharashtra | maharashtra.gov.in

Is Navi Mumbai International MediCity available in India yet?

No, the campus is not available to patients yet because the Memorandum of Understanding was only signed on June 10, 2026. This massive 250-acre project will be developed in phases over the coming years. Once completed, it will be located directly adjacent to the upcoming Navi Mumbai International Airport.

What does Navi Mumbai International MediCity do differently from Apollo Hospitals?

While traditional domestic networks like Apollo focus heavily on standard patient beds, this project combines clinical care with an integrated research centre. Backed by Cleveland Clinic, the campus brings together super-specialty hospitals, biotechnology, and AI-driven genomics. The project also utilises its airport-adjacent location to serve local patients and capture global medical tourism.

Is Navi Mumbai International MediCity worth tracking for Indian patients?

Yes, especially for individuals anticipating complex care needs over the next decade who want to avoid travelling abroad. It is also built for medical students, clinical researchers, and healthcare investors in Maharashtra who prioritise research-backed facilities.

Close-up headshot of Sumit, Lead Curator with clear-framed glasses and a beard.
Sumit Z.

10+ years in Indian media and a career built on understanding how consumer markets move, Sumit leads editorial at Unbox Daily HQ as Editor in Chief. He researches and evaluates launches across Mobility, Lifestyle, Consumer Goods, and Entertainment, studying market positioning, consumer need, and real-world usability before delivering a verdict. His editorial approach starts with the reader's decision, not the brand's announcement.
For editorial queries, launch coverage requests, or collaborations, reach out to Sumit Z. directly at sumitz@unboxdailyhq.com